Clinical Trial Update: Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bioequivalence of sprinkle and capsule lubiprostone formulations versus placebo in chronic idiopathic constipation; trial completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Sucampo Pharma Americas, LLC | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2020-01-14